eases of the central nervous system (CNS) are of an enormous diversity. This provides a major challenge in the pharmacological treatment of brain disorders since they have a greater complexity than most other conditions. The discovery and development of new CNS drugs can be divided into several consecutive stages, which can vary in sequence.